US Patent Issued to Horizon Therapeutics Ireland DAC on April 14 for "Methods for the treatment of thyroid eye disease" (Illinois, California, Puerto Rico Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,787, issued on April 14, was assigned to Horizon Therapeutics Ireland DAC (Dublin).

"Methods for the treatment of thyroid eye disease" was invented by Jeffrey W. Sherman (Lincolnshire, Ill.), Dennis A. Bennett (Rio Grande, Puerto Rico), Srini Ramanathan (Lake Forest, Ill.), Yan Xin (San Carlos, Calif.), Elizabeth Thompson (Lake Forest, Ill.) and Elizabeth O'Neill (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are methods of treating or reducing the severity of thyroid eye disease (TED), also known as thyroid-associated ophthalmopathy (TAO), or Graves' ophthalmopathy or orbitopathy (GO), as well as antibodies, or antig...